Indirubin Derivatives as Dual Inhibitors Targeting Cyclin-Dependent Kinase and Histone Deacetylase for Treating Cancer

Zhuoxian Cao(University of Science and Technology of China), Bin He(Guiyang Medical University), Shuxian Lin(Guiyang Medical University), Fen‐Fen Yang(Guiyang Medical University), Zhicheng Gu(Guiyang Medical University), Hening Lin(Howard Hughes Medical Institute), Yongjun Li(Guiyang Medical University), Pan Wang(Zhejiang University), Jie Wang(Guiyang Medical University), Ting Liu(First Affiliated Hospital of Xi'an Jiaotong University), Jian‐Xiong An(University of Pittsburgh), Yong‐Long Zhao(Guiyang Medical University), Yan Li(University of Science and Technology Beijing)
Journal of Medicinal Chemistry
October 8, 2021
Cited by 57


Related Papers